| Uridine depletion and chemical modification increase Cas9 mRNA activity and reduce immunogenicity without HPLC purification S Vaidyanathan, KT Azizian, AKMA Haque, JM Henderson, A Hendel, ... Molecular Therapy-Nucleic Acids 12, 530-542, 2018 | 217 | 2018 |
| Recent developments in mRNA-based protein supplementation therapy to target lung diseases I Sahu, AKMA Haque, B Weidensee, P Weinmann, MSD Kormann Molecular Therapy 27 (4), 803-823, 2019 | 69 | 2019 |
| Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis AKMA Haque, A Dewerth, JS Antony, J Riethmüller, GR Schweizer, ... Scientific reports 8 (1), 16776, 2018 | 69 | 2018 |
| Gene correction of HBB mutations in CD34+ hematopoietic stem cells using Cas9 mRNA and ssODN donors JS Antony, N Latifi, AKMA Haque, A Lamsfus-Calle, A Daniel-Moreno, ... Molecular and cellular pediatrics 5, 1-7, 2018 | 65 | 2018 |
| A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity S McCafferty, AKMA Haque, A Vandierendonck, B Weidensee, M Plovyt, ... Molecular Therapy 30 (9), 2968-2983, 2022 | 28 | 2022 |
| CRISPR/Cas9 system: A promising technology for the treatment of inherited and neoplastic hematological diseases JS Antony, AKMA Haque, A Lamsfus‐Calle, A Daniel‐Moreno, M Mezger, ... Advances in Cell and Gene Therapy 1 (1), e10, 2018 | 19 | 2018 |
| Inhibition of suicidal erythrocyte death by volasertib A Al Mamun Bhuyan, AKM Ashiqul Haque, I Sahu, H Cao, MSD Kormann, ... Cellular Physiology and Biochemistry 43 (4), 1472-1486, 2017 | 13 | 2017 |
| Modified hCFTR mRNA restores normal lung function in a mouse model of cystic fibrosis AKMA Haque, A Dewerth, JS Antony, J Riethmüller, N Latifi, H Yasar, ... bioRxiv, 202853, 2017 | 4 | 2017 |
| RNA ImmunoGenic Assay: Simple method for detecting immunogenicity of in vitro transcribed mRNA AKMA Haque, P Weinmann, S Biswas, R Handgretinger, M Mezger, ... Advances in Cell and Gene Therapy 3 (2), e79, 2020 | 3 | 2020 |
| RNA immunoGenic assay: a method to detect immunogenicity of in vitro transcribed mRNA in human whole blood AKMA Haque, P Weinmann, S Biswas, R Handgretinger, M Mezger, ... Bio-protocol 10 (24), e3850-e3850, 2020 | 2 | 2020 |
| Assessment of the productivity of fishery in lentic aquasystem from a score of bio-social and techno managerial factors. TK Paik, SK Acharya, SK Chakraborty, S Biswas, A Haque Journal of the Inland Fisheries Society of India 42 (1), 23-32, 2010 | 2 | 2010 |
| Development of gene correction and supplementation therapy based on chemical modification and sequence optimized mRNA for monogenetic diseases AKM Haque Universität Tübingen, 2020 | | 2020 |
| Evaluation and Optimization of Gene Correction Using an All-RNA-Based CRISPR/Cas Approach in Genetic Lung Diseases B Weidensee, I Sahu, AKM Haque, MSD Kormann MOLECULAR THERAPY 27 (4), 251-251, 2019 | | 2019 |
| Chemically Modified hCFTR mRNAs Recuperate Lung Function in a Mouse Model of Cystic Fibrosis MSD Kormann, AKM Haque, N Pedemonte, B Loretz, CM Lehr, ... MOLECULAR THERAPY 27 (4), 303-303, 2019 | | 2019 |
| Targeting Lung Cell Population for Gene Supplementation and Gene Correction Therapy of Cystic Fibrosis I Sahu, AKM Haque, B Weidensee, P Weinmann, B Loretz, CM Lehr, ... MOLECULAR THERAPY 27 (4), 247-247, 2019 | | 2019 |
| Optimizing the utilization of chemically modified Cas9 mRNA/sgRNA against the underlying genetic defect in Surfactant Protein B deficiency and Cystic fibrosis based on … AKMA Haque, B Weidensee, I Sahu, P Weinmann, MSD Kormann MOLECULAR THERAPY 27 (4), 252-252, 2019 | | 2019 |
| Chemical-Modified mRNA Therapy for Cystic Fibrosis by Targeting Lung Cells I Sahu, AKMA Haque, GR Schweizer, B Weidensee, P Weinmann, ... COPD: Journal of Chronic Obstructive Pulmonary Disease 16 (2), 209-210, 2019 | | 2019 |
| Topical and Systemic Administration of Chemically Modified HCFTR mRNA Restores Lung Function in a Mouse Model of Cystic Fibrosis AKM Haque MOLECULAR THERAPY 25 (5), 143-144, 2017 | | 2017 |
| Assessment of value-addition gap in banana (Musa sp.) enterprise in terms of some socio-economic and personal factors. SK Acharya, S Biswas, S Dev, A Haque | | 2007 |
| Uncovering the Possibilities of Self-Amplifying Rna in Vaccine Development to Tackle Future Viral Outbreaks and Potential Pandemics A Vandierendonck, I Sahu, K Poelaert, S Valembois, AKM Haque, ... 16TH VACCINE CONGRESS P 2, 0 | | |
